Related Experiment Videos
Adding to complexity: comorbidity in paediatric rheumatic disease
Eve M D Smith1, Helen E Foster, Michael W Beresford
1Paediatric Rheumatology, Great North Children's Hospital, Queen Victoria Road, Newcastle Upon Tyne NE1 4LP, UK. evemdsmith@yahoo.co.uk
Insights
Novel biologic therapies improve outcomes for children with rheumatic diseases. Addressing comorbidities like cardiovascular, renal, and growth issues is crucial for enhancing quality of life and treatment effectiveness.
Area of Science:
- Pediatric Rheumatology
- Internal Medicine
- Clinical Therapeutics
Background:
- Biologic agents represent novel therapies for pediatric rheumatic diseases.
- Comorbidities associated with rheumatic diseases and their treatments present significant challenges.
- Effective management of comorbidities is vital for improving patient outcomes.
Purpose of the Study:
- To review key comorbidities frequently encountered in pediatric rheumatology.
- To highlight the importance of prompt recognition and management of these comorbidities.
- To discuss the impact of rheumatic diseases and treatments on various aspects of child health.
Main Methods:
- Literature review of comorbidities in pediatric rheumatology.
- Discussion of cardiovascular, renal, genito-urinary, and visual comorbidities.
- Analysis of bone health, drug-related issues, growth, and puberty impacts.
Main Results:
- Biologic therapies offer improved long-term prognosis for children with rheumatic diseases.
- Comorbidities significantly impact quality of life and treatment effectiveness.
- Specific areas of comorbidity include cardiovascular, renal, genito-urinary, visual, bone health, and growth/puberty.
Conclusions:
- Prompt recognition and management of comorbidities are essential in pediatric rheumatology.
- Addressing comorbidities optimizes treatment effectiveness and overall prognosis.
- Comprehensive care considering comorbidities improves long-term outcomes for children with rheumatic diseases.
Abstract:
Novel therapies including biologic agents offer paediatric rheumatologists significant opportunity to improve long-term prognosis for children with rheumatic disease. However, comorbidities related to the diseases themselves and their treatments pose specific challenges to be overcome. Prompt recognition and appropriate management will improve quality of life, effectiveness of treatment and overall prognosis. In this review, we discuss key areas of comorbidity frequently encountered in paediatric rheumatology including cardiovascular, renal, genito-urinary and visual comorbidity, bone health, drug-related issues and the influence of rheumatic disease on growth and puberty.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pneumonia III: Complications and Assessment